Anthony E.J. Dubois

Anthony E.J. Dubois

Auto-generated profile, based on publicly available information

Anthony E.J. Dubois

University of Groningen, University Medical Centre Groningen, Department of Pediatric Pulmonology and Pediatric Allergy, Groningen, Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2018 in Allergy
Verified
Journal Article
Open access
PDF file
MPM. E. Pettersson
M. E. Pettersson
GKG. H. Koppelman
G. H. Koppelman
BBB. M. J. Flokstra‐De Blok
B. M. J. Flokstra‐De Blok
BKB. J. Kollen
B. J. Kollen
ADA. E. J. Dubois
A. E. J. Dubois
Background: There is currently considerable uncertainty regarding what the predictors of the severity of diagnostic or accidental food allergic reactions are, and to what extent the severity of such reactions can be predicted.Objective: To identify predictors for the severity of diagnostic and accidental food allergic reactions and to quantify their impact.Methods: The study population consisted of children with a double‐blind, placebo‐controlled food challenge (DBPCFC)–confirmed food allergy to milk, egg, peanut, cashew nut, and/or hazelnut. The data were analyzed using multiple linear regression analysis. Missing values were imputed using multiple imputation techniques. Two scoring systems were used to determine the severity of the reactions.Results: A total of 734 children were included. Independent predictors for the severity of the DBPCFC reaction were age (B = 0.04, P = .001), skin prick test ratio (B = 0.30, P < .001), eliciting dose (B = −0.09, P < .001), level of specific immunoglobulin E (B = 0.15, P < .001), reaction time during the DBPCFC (B = −0.01, P = .004), and severity of accidental reaction (B = 0.08, P = .015). The total explained variance of this model was 23.5%, and the eliciting dose only contributed 4.4% to the model. Independent predictors for more severe accidental reactions with an explained variance of 7.3% were age (B = 0.03, P = .014), milk as causative food (B = 0.77, P < .001), cashew as causative food (B = 0.54, P < .001), history of atopic dermatitis (B = −0.47, P = .006), and severity of DBPCFC reaction (B = 0.12, P = .003).Conclusions: The severity of DBPCFCs and accidental reactions to food remains largely unpredictable. Clinicians should not use the eliciting dose obtained from a graded food challenge for the purposes of making risk‐related management decisions.

9 February 2018 in Allergy
Verified
Journal Article
Open access
PDF file
ADAnthony E.J. Dubois
Anthony E.J. Dubois
PTPaul Turner
Paul Turner
JHJonathan Hourihane
Jonathan Hourihane
BBBarbara Ballmer‐Weber
Barbara Ballmer‐Weber
KBKirsten Beyer
Kirsten Beyer
RCRené W.R. Crevel
René W.R. Crevel
Quantitative risk assessment (QRA) for food allergens has made considerable progress in recent years, yet acceptability of its outcomes remains stymied because of the limited extent to which it has been possible to incorporate severity as a variable. Reaction severity, particularly following accidental exposure, depends on multiple factors, related to the allergen, the host and any treatments, which might be administered. Some of these factors are plausibly still unknown. Quantitative risk assessment shows that limiting exposure through control of dose reduces the rates of reactions in allergic populations, but its impact on the relative frequency of severe reactions at different doses is unclear. Food challenge studies suggest that the relationship between dose of allergenic food and reaction severity is complex even under relatively controlled conditions. Because of these complexities, epidemiological studies provide very limited insight into this aspect of the dose‐response relationship. Emerging data from single‐dose challenges suggest that graded food challenges may overestimate the rate of severe reactions. It may be necessary to generate new data (such as those from single‐dose challenges) to reliably identify the effect of dose on severity for use in QRA. Success will reduce uncertainty in the susceptible population and improve consumer choice.

1 February 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
JWJulie Wang
Julie Wang
DJDouglas T. Johnston
Douglas T. Johnston
JLJay A. Lieberman
Jay A. Lieberman
CBChristine Birchwood
Christine Birchwood
SASarah Acaster
Sarah Acaster
JHJonathan O'B. Hourihane
Jonathan O'B. Hourihane